C3 and metabolic dysfunction-associated steatohepatitis: On the other hand, IgG-immune complex has been reported to initiate the classical pathway to promote the production of C3 (C3a) [37,50] and elevated IgG was correlated with risk of hepatic decompensation in MASH patients [9].